This study will provide ongoing, high quality data on the safety, performance, and clinical benefits of Abbott's EP devices in a real-world setting.
Study Type
OBSERVATIONAL
Enrollment
5,003
Standard of care mapping and/or ablation
KH Wiener Neustadt
Wiener Neustadt, Lower Austria, Austria
The proportion of patients with a device- and/or procedure-related Serious Adverse Event
that occurred within 7-days of the procedure.
Time frame: 7-days
The proportion of procedures that achieved acute success.
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
A. ö. Krankenhaus der Elisabethinen Linz
Linz, UPR AUS, Austria
FN U sv. Anny v Brno
Brno, Moravia-Silesia, Czechia
Pole Sante Republique
Clermont-Ferrand, Auvergne, France
Polyclinique des Fleurs
Ollioules, Provence-Alpes-Azur, France
Clinique Rhône-Durance
Avignon, Provence, France
Deutsches Herzzentrum München des Freistaates Bayern
München, Bavaria, Germany
Medizinische Einrichtungen der Universität zu Köln
Cologne, North Rhine-Westphalia, Germany
Herzzentrum Dresden GmbH Universitätsklinik
Dresden, Germany
Semmelweis University
Budapest, Budapest, Hungary
...and 16 more locations